Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
Tài liệu tham khảo
Greenspan, 1994, Treatment of oropharyngeal candidiasis in HIV-positive patients, J Am Acad Dermatol, 31, S51, 10.1016/S0190-9622(08)81268-6
Van Meter, 1994, A study of oral candidiasis in HIV-positive patients, J Dent Hyg, 68, 30
Klein, 1984, Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome, NEJM, 311, 354, 10.1056/NEJM198408093110602
Lifson, 1994, Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts, AIDS, 8, 73, 10.1097/00002030-199401000-00011
Koletar, 1990, Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients with human immunodeficiency virus, Antimicrob Agents Chemother, 34, 2267, 10.1128/AAC.34.11.2267
Pons, 1993, Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches, J Acquired Immune Defic Syndr, 6, 1311
Sangeorzan, 1994, Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance, Am J Med, 97, 339, 10.1016/0002-9343(94)90300-X
De Wit, 1989, Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS, Lancet, 1, 746, 10.1016/S0140-6736(89)92572-5
Cleary, 1992, Itraconazole in antifungal therapy, Ann Pharmacother, 26, 502, 10.1177/106002809202600411
Lake-Bakaar, 1988, Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 109, 471, 10.7326/0003-4819-109-6-471
Boken, 1993, Fluconazole-resistant Candida albicans, Clin Infect Dis, 17, 1018, 10.1093/clinids/17.6.1018
Goff, 1995, Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles, Clin Infect Dis, 20, 77, 10.1093/clinids/20.1.77
Newman, 1994, Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS, Clin Infect Dis, 19, 684, 10.1093/clinids/19.4.684
Rex, 1995, Resistance of Candida species to fluconazole, Antimicrob Agents Chemother, 39, 1, 10.1128/AAC.39.1.1
Hay, 1987, First international symposium on itraconazole: A summary, Rev Infect Dis, 9, S1, 10.1093/clinids/9.Supplement_1.S1
Barchiesi, 1994, In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus, Antimicrob Agents Chemother, 38, 1530, 10.1128/AAC.38.7.1530
Blatchford, 1990, Treatment of oral candidosis with itraconazole: A review, J Am Acad Dermatol, 23, 565, 10.1016/0190-9622(90)70256-H
Barone, 1993, Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers, Antimicrob Agents Chemother, 37, 778, 10.1128/AAC.37.4.778
Hardin, 1988, Pharmacokinetics of itraconazole following oral administration to normal volunteers, Antimicrob Agents Chemother, 32, 1310, 10.1128/AAC.32.9.1310
Smith, 1991, Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV, AIDS, 5, 1367, 10.1097/00002030-199111000-00014
Hostetler, 1992, Effect of cyclodextrin on the pharmacology of antifungal oral azoles, Antimicrob Agents Chemother, 36, 477, 10.1128/AAC.36.2.477
Barone, 691997, Enhanced bioavailability of itraconazole (ITR) solution compared with capsules in healthy volunteers, Presented at the Annual Meeting of the American College of Clinical Pharmacy
Desmet, 20231989, Treatment of oral candidosis in AIDS patients with itraconazole oral solution, Presented at the Third Symposium, Topics in Mycology: Mycoses in AIDS Patients
Powderly, 1995, A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection, NEJM, 332, 700, 10.1056/NEJM199503163321102